Publications (22)46.63 Total impact
-
Article: [Bilateral pseudo-Kaposi sarcoma in upper limbs].
[show abstract] [hide abstract]
ABSTRACT: Acroangiodermatitis or pseudo-Kaposi sarcoma is an angioproliferative, self-limited entity that includes a group of diseases, congenital or acquired, with cutaneous lesions similar to Kaposi sarcoma (KS). This term can lead to confusion because it comprises several entities that are completely different, nonetheless, it has an important clinical value as it guides the diagnosis and management of these patients. We report the case of a 67-year-old patient with lesions of acroangiodermatitis in both forearms secondary to arteriovenous shunts from hemodialysis. Doppler ultrasound showed a former arteriovenous fistula in addition to the one already known. Immunohistochemical study showed CD34+ staining in endotelial cells and absence of HHV-8 expression.Actas Dermo-Sifiliográficas 06/2007; 98(4):268-70. -
Article: [Fatal Sweet syndrome associated to chronic idiopathic systemic inflammatory response syndrome].
[show abstract] [hide abstract]
ABSTRACT: Sweet syndrome is one of the cutaneous processes more frequently associated to systemic diseases. Its association to the systemic inflammatory response syndrome has rarely been described. We report a case of chronic and relapsing Sweet syndrome associated to a chronic and idiopathic systemic inflammatory response syndrome that lasted seven years and proved fatal to the patient. Among the rare cases of Sweet syndrome associated to a systemic inflammatory response syndrome that have been described there have not been any fatal cases as occurred with our patient.Actas Dermo-Sifiliográficas 03/2007; 98(2):105-8. -
Article: A case of Sweet's syndrome and pemphigus vulgaris.
Journal of the European Academy of Dermatology and Venereology 12/2004; 18(6):745-6. · 2.98 Impact Factor -
Article: Lymphangiectatic variant of pilomatricoma.
Journal of the European Academy of Dermatology and Venereology 10/2004; 18(5):575-6. · 2.98 Impact Factor -
Article: Fixed drug eruption from piroxicam.
[show abstract] [hide abstract]
ABSTRACT: The pathogenetic mechanism of fixed drug eruption (FDE) is still unknown. One of the most common causes of FDE is the use of nonsteroidal antiinflammatory drugs (NSAIDs). Oxicams are in the NSAID group and piroxicam is one of the most used of these drugs. FDE caused by piroxicam is rare but a few cases have been reported. Patch tests are useful for diagnosing some cases of FDE; they give variable results on previously affected skin while no reaction appears on unaffected skin. Some cases of cross-sensitivity among piroxicam and other substances have been reported. We report two new cases of FDE due to piroxicam with negative patch test on normal skin and positive results on affected skin.Journal of the European Academy of Dermatology and Venereology 10/2004; 18(5):586-7. · 2.98 Impact Factor -
Article: Porokeratotic eccrine ostial and dermal duct naevus: treatment with carbon dioxide laser
British Journal of Dermatology 12/2001; 141(6):1136 - 1152. · 3.67 Impact Factor -
Article: Cutaneous T-cell lymphoma presenting as disseminated, pigmented, purpura-like eruption.
International Journal of Dermatology 03/2001; 40(2):140-4. · 1.14 Impact Factor -
Article: Dermatomyositis and mucinosis.
[show abstract] [hide abstract]
ABSTRACT: Mucin deposition is a common feature in autoimmune collagen diseases including dermatomyositis. Nevertheless, clinical manifestations of mucinosis are uncommon in patients with dermatomyositis. Two cases of mucinosis associated with dermatomyositis are reported. A 53-year-old woman presented with symmetrical plaques on the upper limbs formed by the coalescence of small, violaceous papules. In addition, she showed the typical cutaneous and muscle features of dermatomyositis. A 44-year-old woman with dermatomyositis of 5 years' evolution developed linear, flesh-colored papules across the flexural creases of her palms and fingers. Skin biopsy of the upper limb lesions in the first patient showed epidermal changes compatible with dermatomyositis and dermal mucin deposition. Histopathologic examination of the palmar lesions of the second patient showed less intense epidermal changes of dermatomyositis and dermal mucin deposition. Mucin deposition in patients with dermatomyositis may have an unusual clinical presentation, and it should be considered in the differential diagnosis of atypical cutaneous lesions in these patients.International Journal of Dermatology 03/2001; 40(2):120-4. · 1.14 Impact Factor -
Article: Dorfman--Chanarin syndrome (neutral lipid storage disease): new clinical features.
British Journal of Dermatology 03/2001; 144(2):430-2. · 3.67 Impact Factor -
Article: Pityriasis lichenoides-like exanthem and primary infection by Epstein-Barr virus.
International Journal of Dermatology 03/2000; 39(2):156-9. · 1.14 Impact Factor -
Article: Systemic lupus erythematosus presenting with a reticular erythematous mucinosis-like condition.
[show abstract] [hide abstract]
ABSTRACT: We report the case of a woman with clinical and histopathological features of reticular erythematous mucinosis syndrome (REM) who six years later developed diagnostic criteria for systemic lupus erythematosus (SLE). Two biopsies performed at the same area initially showed mucin dermal deposits and further development of characteristic dermo-epidermal changes of lupus erythematosus. Our findings suggest that SLE may present with an REM-like condition.Lupus 02/2000; 9(2):144-6. · 2.34 Impact Factor -
Article: Porokeratotic eccrine ostial and dermal duct naevus: treatment with carbon dioxide laser.
British Journal of Dermatology 01/2000; 141(6):1144-5. · 3.67 Impact Factor -
Article: Ecthyma gangrenosum-like eruption associated with Morganella morganii infection.
[show abstract] [hide abstract]
ABSTRACT: Ecthyma gangrenosum is considered as a pathognomonic sign of Pseudomonas aeruginosa sepsis. Lesions similar to ecthyma gangrenosum may be caused by other organisms. We report a case of an ecthyma gangrenosum-like eruption caused by Morganella morganii, a Gram-negative bacillus.British Journal of Dermatology 10/1998; 139(3):520-1. · 3.67 Impact Factor -
Article: Flexural purpura and Epstein-Barr virus infection.
International Journal of Dermatology 02/1998; 37(2):130-2. · 1.14 Impact Factor -
Article: Reticular erythematous mucinosis syndrome. Report of a case with positive immunofluorescence.
[show abstract] [hide abstract]
ABSTRACT: We report a case with the clinical and histological features of the reticular erythematous mucinosis syndrome (REM), in which there was moderate, continuous, fine, granular, IgM deposition along the basal layer. Similar direct immunofluorescence results have been reported in only two previous cases.Clinical and Experimental Dermatology 09/1997; 22(5):234-6. · 1.20 Impact Factor -
Article: Rubinstein-Taybi syndrome with piebaldism.
[show abstract] [hide abstract]
ABSTRACT: A young girl is reported suffering from multiple congenital anomalies typical of Rubinstein-Taybi syndrome, in association with cutaneous lesions of piebaldism and occipital poliosis. Clinical characteristics of both entities are described and cutaneous manifestations of Rubinstein-Taybi syndrome are reviewed. To the best of our knowledge, this is the first case reporting such an association.Clinical and Experimental Dermatology 04/1994; 19(2):170-2. · 1.20 Impact Factor -
Article: [Destructive and painful acute ulcer of the penis].
Enfermedades Infecciosas y Microbiología Clínica 06/1990; 8(5):315-6. · 1.49 Impact Factor -
Article: Cutaneous ulceration as a sign of methotrexate toxicity.
[show abstract] [hide abstract]
ABSTRACT: Methotrexate (MTX) inhibits DNA synthesis by competition with dihydrofolate reductase. Adverse cutaneous reactions to MTX are usually dose-related and have been mainly reported in patients receiving extremely large doses of chemotherapy. Painful erosion of psoriatic plaques has been often reported as an early sign of MTX toxicity, but cutaneous ulceration as a sign of MTX toxicity in patients without psoriasis has only been described in one case. We report a patient with rheumatoid arthritis and without psoriasis who developed cutaneous ulceration on the knuckles as a sign of MTX toxicity. Cutaneous ulceration by MTX toxicity is an exclusion diagnosis and its pathogenic mechanism may be multifactorial, including direct toxicity of the drug in addition to local factors.European journal of dermatology: EJD 11(5):450-2. · 2.53 Impact Factor -
Article: Linear immunoglobulin A bullous dermatosis induced by gemcitabine.
[show abstract] [hide abstract]
ABSTRACT: To report a case of linear immunoglobulin (Ig) A bullous dermatosis (LABD) induced by gemcitabine. A 59-year-old man was diagnosed with squamous-cell carcinoma of the lung in T4N2M0 stage and treated with cisplatin, vinorelbine, and gemcitabine. Twenty-four hours after the administration of gemcitabine, a symmetric, bullous, herpetiform eruption appeared on his trunk and upper limbs. Histopathologic examination and direct immunofluorescence test were consistent with IgA bullous dermatosis. Cutaneous lesions resolved two weeks after the drug was withdrawn and topical steroid treatment was instituted. Drug-induced LABD is a variant of classic or idiopathic LABD. Vancomycin is the most frequently implicated drug, but other agents have been reported to cause LABD. According to the Naranjo probability scale, the relationship of gemcitabine treatment with cutaneous eruption in our patient is possible. We report the first case of gemcitabine-induced LABD. Clinicians should monitor patients receiving this drug for signs of LABD.Annals of Pharmacotherapy 35(7-8):891-3. · 2.13 Impact Factor -
Article: Guess what! Superficial migratory thrombophlebitis. Thromboangiitis obliterans (Buerger's disease).
European journal of dermatology: EJD 10(5):405-6. · 2.53 Impact Factor
